Disease | c syndrome |
Phenotype | C0019204|hepatocellular carcinoma |
Sentences | 8 |
PubMedID- 25331727 | Background: only a few papers have focused on the surgical outcomes of patients with hepatocellular carcinoma (hcc) associated with the metabolic syndrome. |
PubMedID- 24396608 | Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma. |
PubMedID- 23147992 | Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. |
PubMedID- 25646890 | Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: a multicenter matched analysis with hcv-related hcc. |
PubMedID- 21911994 | Polymyositis as a paraneoplastic syndrome associated with hepatocellular carcinoma is quite rare; only a few cases have been reported. |
PubMedID- 24069511 | At the same time it is also important to quantify the risk of hepatocellular carcinoma associated with the metabolic syndrome in a prospective setting and develop surveillance recommendations for detection of hepatocellular carcinoma in patients with metabolic syndrome. |
PubMedID- 26157820 | Cholangiopathy with biliary inflammation and necrosis has been recognized as a result of post-liver transplantation ischemic injury, particularly with livers donated after cardiac death (dcd),8 surgical complication of laparoscopic cholecystectomy,9 advanced hiv/aids cholangiopathy,10 after radiofrequency ablation for hepatocellular carcinoma,11 and in patients with hemophagocytic syndrome.12 however, to our knowledge, this is the first report of infectious biliary necrosis and cholangiopathy as a complication of ercp. |
PubMedID- 24480222 | Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma. |
Page: 1